The Leadership Team at Pyxis Oncology is responsible for guiding the company's strategic vision and operational execution in developing innovative biologics for cancer treatment. This diverse team oversees research, clinical operations, regulatory affairs, and financial management, ensuring efficient collaboration across departments to accelerate the advancement of their differentiated portfolio of antibody-drug conjugates and immunotherapies. By fostering a culture of scientific excellence and strategic planning, the Leadership Team plays a critical role in driving the company’s mission to improve patient outcomes in difficult-to-treat cancers.
Balu Balasubramanian
Interim CTO
Chuan Shen
Principal Scientist
Jan Pinkas
Chief Scientific Officer
Ken Kobayashi
Chief Medical Officer
Krystal Watkins
Principal Scientist
Lara S. Sullivan
Chief Executive Officer
Pamela Connealy
Chief Financial Officer & Chie...
Renpeng Liu
Principal Scientist (associate...
Shui He
SVP Biometrics
Stan Szpindor
Vice President, R&d Quality
View all